AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: Mathew, S Shurtleff, SA Raimondi, SC
Citation: S. Mathew et al., Novel cryptic, complex rearrangements involving ETV6-CBFA2 (TEL-AMLI) genes identified by fluorescence in situ hybridization in pediatric patients with acute lymphoblastic leukemia, GENE CHROM, 32(2), 2001, pp. 188-193

Authors: Razzouk, BI Raimondi, SC Srivastava, DK Pritchard, M Behm, FG Tong, X Sandlund, JT Rubnitz, JE Pui, CH Ribeiro, RC
Citation: Bi. Razzouk et al., Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience, LEUKEMIA, 15(9), 2001, pp. 1326-1330

Authors: Slater, RM Drunen, EV Kroes, WG Weghuis, DO van den Berg, E Smit, EM van der Does-van den Berg, A van Wering, E Hahlen, K Carroll, AJ Raimondi, SC Beverloo, HB
Citation: Rm. Slater et al., t(7;12)(q36;p13) and t(7;12)(q32;p13) - translocations involving ETV6 in children 18 months of age or younger with myeloid disorders, LEUKEMIA, 15(6), 2001, pp. 915-920

Authors: Mathew, S Rao, PH Dalton, J Downing, JR Raimondi, SC
Citation: S. Mathew et al., Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia, LEUKEMIA, 15(3), 2001, pp. 468-472

Authors: Krance, RA Hurwitz, CA Head, DR Raimondi, SC Behm, FG Crews, KR Srivastava, DK Mahmoud, H Roberts, WM Tong, X Blakley, RL Ribeiro, RC
Citation: Ra. Krance et al., Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases, J CL ONCOL, 19(11), 2001, pp. 2804-2811

Authors: Blanco, JG Dervieux, T Edick, MJ Mehta, PK Rubnitz, JE Shurtleff, S Raimondi, SC Behm, FG Pui, CH Relling, MV
Citation: Jg. Blanco et al., Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia, P NAS US, 98(18), 2001, pp. 10338-10343

Authors: Srivannaboon, K Shanafelt, AB Todisco, E Porte, CP Behm, FG Raimondi, SC Pui, CH Campana, D
Citation: K. Srivannaboon et al., Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acutelymphoblastic leukemia cells, BLOOD, 97(3), 2001, pp. 752-758

Authors: Athale, UH Razzouk, BI Raimondi, SC Tong, X Behm, FG Head, DR Srivastava, DK Rubnitz, JE Bowman, L Pui, CH Ribeiro, RC
Citation: Uh. Athale et al., Biology and outcome of childhood acute megakaryoblastic leukemia: a singleinstitution's experience, BLOOD, 97(12), 2001, pp. 3727-3732

Authors: Mathew, S Head, D Rubnitz, JE Raimondi, SC
Citation: S. Mathew et al., Concurrent translocations of MLL and CBFA2 (AMLI) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia, GENE CHROM, 28(2), 2000, pp. 227-232

Authors: Mathew, S Head, D Rodriguez-Galindo, C Raimondi, SC
Citation: S. Mathew et al., Trisomy of the long arm of chromosome 1 resulting in a dicentric derivative (6)t(1;6) chromosome in a child with myelodysplastic syndrome following treatment for a primitive neuroectodermal tumor, LEUK LYMPH, 37(1-2), 2000, pp. 213

Authors: Chang, M Raimondi, SC Ravindranath, Y Carroll, AJ Camitta, B Gresik, MV Steuber, CP Weinstein, H
Citation: M. Chang et al., Prognostic factors in children and adolescents with acute myeloid leukemia(excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POC) Study 8821, LEUKEMIA, 14(7), 2000, pp. 1201-1207

Authors: Mathew, S Lorsbach, RB Shearer, P Sandlund, JT Raimondi, SC
Citation: S. Mathew et al., Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia, LEUKEMIA, 14(7), 2000, pp. 1314-1315

Authors: Pui, CH Raimondi, SC Srivastava, DK Tong, X Behm, FG Razzouk, B Rubnitz, JE Sandlund, JT Evans, WE Ribeiro, R
Citation: Ch. Pui et al., Prognostic factors in infants with acute myeloid leukemia, LEUKEMIA, 14(4), 2000, pp. 684-687

Authors: Woo, MH Shuster, JJ Chen, C Bash, RO Behm, FG Camitta, B Felix, CA Kamen, BA Pui, CH Raimondi, SC Winick, NJ Amylon, MD Relling, MV
Citation: Mh. Woo et al., Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies, LEUKEMIA, 14(2), 2000, pp. 232-237

Authors: Pui, CH Boyett, JM Rivera, GK Hancock, ML Sandlund, JT Ribeiro, RC Rubnitz, JE Behm, FG Raimondi, SC Gajjar, A Razzouk, B Campana, D Kun, LE Relling, MV Evans, WE
Citation: Ch. Pui et al., Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital, LEUKEMIA, 14(12), 2000, pp. 2286-2294

Authors: Haga, SB Fu, S Karp, JE Ross, DD Williams, DM Hankins, WD Behm, F Ruscetti, FW Chang, M Smith, BD Becton, D Raimondi, SC Berg, PE
Citation: Sb. Haga et al., BP1, a new homeobox gene, is frequently expressed in acute leukemias, LEUKEMIA, 14(11), 2000, pp. 1867-1875

Authors: Arnaout, MK Radomski, KM Srivastava, DK Tong, X Belt, JR Raimondi, SC Behm, FG Santana, VM Crom, WR Mirro, J Ribeiro, RC
Citation: Mk. Arnaout et al., Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- andlong-term effects, LEUKEMIA, 14(10), 2000, pp. 1736-1742

Authors: Raimondi, SC
Citation: Sc. Raimondi, Fluorescence in situ hybridization: Molecular probes for diagnosis of pediatric neoplastic diseases, CANCER INV, 18(2), 2000, pp. 135-147

Authors: Morgan, SE Cadena, RS Raimondi, SC Beck, WT
Citation: Se. Morgan et al., Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase II alpha and altered G(2)/M checkpoint and apoptotic responses, MOLEC PHARM, 57(2), 2000, pp. 296-307

Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2591-2596

Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2691-2696

Authors: Todisco, E Suzuki, T Srivannaboon, K Coustan-Smith, E Raimondi, SC Behm, FG Kitanaka, A Campana, D
Citation: E. Todisco et al., CD38 ligation inhibits normal and leukemic myelopoiesis, BLOOD, 95(2), 2000, pp. 535-542

Authors: Raynaud, SD Dastugue, N Zoccola, D Shurtleff, SA Mathew, S Raimondi, SC
Citation: Sd. Raynaud et al., Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia, LEUKEMIA, 13(9), 1999, pp. 1325-1330

Authors: Mathew, S Behm, FG Dalton, J Raimondi, SC
Citation: S. Mathew et al., Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities, LEUKEMIA, 13(11), 1999, pp. 1713-1720

Authors: Rubnitz, JE Camitta, BM Mahmoud, H Raimondi, SC Carroll, AJ Borowitz, MJ Shuster, JJ Link, MP Pullen, DJ Downing, JR Behm, FG Pui, CH
Citation: Je. Rubnitz et al., Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation, J CL ONCOL, 17(1), 1999, pp. 191-196
Risultati: 1-25 | 26-30